Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Coons

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Expert Opinion on Drug Safety|March 28, 2014
An evidence based systematic review of remifentanil associated opioid-induced hyperalgesiaRyan M Rivosecchi, Mark J Rice, Pamela L Smithburger, et al.
The American Journal of Cardiology|December 9, 2022
Impact of a Medication Optimization Clinic on Heart Failure HospitalizationsJames C Coons, Jennifer Kliner, Michael A Mathier, et al.
The Annals of Pharmacotherapy|September 5, 2020
A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa ConcentrationsMarissa N Levito, James C Coons, Margaret M Verrico, et al.
American Journal of Pharmaceutical Education|December 25, 2019
A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students' Postgraduate ReadinessJames C Coons, Neal Benedict, Amy Seybert, et al.
American Journal of Pharmaceutical Education|March 5, 2016
Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic TestingSolomon M Adams, Kacey B Anderson, James C Coons, et al.
Therapeutic Advances in Respiratory Disease|April 30, 2021
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertensionJames C Coons, Karryn Crisamore, Solomon Adams, et al.
Pulmonary Circulation|December 5, 2017
Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertensionJames C Coons, Cheryl Bunner, David C Ishizawar, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2024
Empowering personalized pharmacogenomics with generative AI solutionsMullai Murugan, Bo Yuan, Eric Venner, et al.
Journal of Interventional Cardiology|November 28, 2019
Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume CentersBrent N Reed, Robert J DiDomenico, J Erin Allender, et al.
Pharmacotherapy|July 26, 2017
Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory SupportJ Erin Allender, Brent N Reed, Jenna L Foster, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Safety|March 28, 2014
An evidence based systematic review of remifentanil associated opioid-induced hyperalgesiaRyan M Rivosecchi, Mark J Rice, Pamela L Smithburger, et al.
The American Journal of Cardiology|December 9, 2022
Impact of a Medication Optimization Clinic on Heart Failure HospitalizationsJames C Coons, Jennifer Kliner, Michael A Mathier, et al.
The Annals of Pharmacotherapy|September 5, 2020
A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa ConcentrationsMarissa N Levito, James C Coons, Margaret M Verrico, et al.
American Journal of Pharmaceutical Education|December 25, 2019
A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students' Postgraduate ReadinessJames C Coons, Neal Benedict, Amy Seybert, et al.
American Journal of Pharmaceutical Education|March 5, 2016
Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic TestingSolomon M Adams, Kacey B Anderson, James C Coons, et al.
Therapeutic Advances in Respiratory Disease|April 30, 2021
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertensionJames C Coons, Karryn Crisamore, Solomon Adams, et al.
Pulmonary Circulation|December 5, 2017
Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertensionJames C Coons, Cheryl Bunner, David C Ishizawar, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2024
Empowering personalized pharmacogenomics with generative AI solutionsMullai Murugan, Bo Yuan, Eric Venner, et al.
Journal of Interventional Cardiology|November 28, 2019
Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume CentersBrent N Reed, Robert J DiDomenico, J Erin Allender, et al.
Pharmacotherapy|July 26, 2017
Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory SupportJ Erin Allender, Brent N Reed, Jenna L Foster, et al.
Pageof 8